insights_auto
Why is ALA up 2.04%?
Dive Deeperchevron_right
ALA:ASX
Arovella Therapeutics Ltd
A$0.050
arrow_upward
+2.04%(+0.0010) 1D
Nov 16, 12:31:36 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALA...
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
59.23M
Avg. vol.
599.54K
Volume
220.19K
52-wk high
A$0.10
52-wk low
A$0.05
EPS
-A$0.01
Shares outstanding
1.21B
No. of employees
14
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
59.23M
Avg. vol.
599.54K
Volume
220.19K
52-wk high
A$0.10
52-wk low
A$0.05
EPS
-A$0.01
Shares outstanding
1.21B
No. of employees
14
News stories
From web sources and news partners
investingLive
·
2 hours ago
Morgan Stanley goes max overweight global stocks, sees 15% S&P 500 upside on AI capex
The Motley Fool
·
10 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
1 day ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
BigGo Finance
·
15 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
About Arovella Therapeutics Ltd
CEOMichael Baker
Employees14
Founded1999
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitearovella.com